| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/07/1999 | WO1999000145A1 Antigenic modulation of viral particules |
| 01/07/1999 | WO1999000123A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
| 01/07/1999 | WO1999000010A2 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 01/07/1999 | WO1999000008A1 Agrobacterium-mediated transformation and efficient regeneration of cacao |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998044141A3 Insect expression vectors |
| 01/07/1999 | WO1998042824A3 Methods for selecting cells and their uses |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998041097A3 Non-retrograding starch in food products |
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | WO1998035984A3 Compositions and methods for highly efficient transfection |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | WO1998032853A3 Secreted proteins and polynucleotides encoding them |
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889134A1 $g(b)-FRUCTOFURANOSIDASE AND ITS GENE, METHOD OF ISOLATING $g(b)-FRUCTOFURANOSIDASE GENE, SYSTEM FOR PRODUCING $g(b)-FRUCTOFURANOSIDASE, AND $g(b)-FRUCTOFURANOSIDASE VARIANT |
| 01/07/1999 | EP0889133A2 Process for producing microbial transglutaminase |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889125A1 Monoclonal antibody 4G8b4b12 to human FLT3/FLK2 |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889121A1 Cancer cells capable of tumorigenesis but incapable of infiltration and metastasis, process for preparing the same, and method for screening gene relating to metastasis by using the same |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888777A2 Recombinant bovine herpesvirus type 1 polyptpetides and vaccines |
| 01/07/1999 | EP0888697A1 Fixed wireless terminals in network management method and apparatus |
| 01/07/1999 | EP0888591A1 Computational method for designing chemical structures having common functional characteristics |
| 01/07/1999 | EP0888551A1 Method for predicting the outcome of hepatitis b infection |
| 01/07/1999 | EP0888545A1 Super-paramagnetic particles with increased r 1? relaxivity, processes for producing said particles and use thereof |
| 01/07/1999 | EP0888540A1 Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway |
| 01/07/1999 | EP0888471A1 Method and device for making composite sheets |
| 01/07/1999 | EP0888461A1 Tissue remodeling proteins |
| 01/07/1999 | EP0888460A1 Methods of screening for a tumor or tumor progression to the metastatic state |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888455A1 Alkaline cellulase and method of producing same |
| 01/07/1999 | EP0888454A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888451A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888384A2 Conjugate for modifying interactions between proteins |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888379A1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 01/07/1999 | EP0888378A1 An optimal procedure for isolation of mutant mitochondrial alleles |
| 01/07/1999 | EP0888377A1 MURINE $g(a)(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 01/07/1999 | EP0888375A1 A novel disintegrin metalloprotease and methods of use |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888367A1 Isolated rna molecules which bind to arginine and uses thereof |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888054A1 Targeted site specific drug delivery compositions and method of use |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0888046A1 Method of protein production using mitochondrial translation system |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0646015B1 Contraceptive vaccine |
| 01/07/1999 | EP0625195B1 Therapy of central nervous system by genetically modified cells |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0587788B1 Methods and compositions of genetic stress response systems |
| 01/07/1999 | EP0525076B1 Recombinant bile salt activated lipases |
| 01/07/1999 | DE19828726A1 Preparation of bio-artificial transplant |
| 01/07/1999 | DE19803070C1 Enzyme (complex) preparation from plant seeds |
| 01/07/1999 | DE19741292C1 New use of aluminium |
| 01/07/1999 | DE19726823A1 Detoxifizierungsproteine Detoxifizierungsproteine |
| 01/07/1999 | CA2427749A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | CA2296015A1 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295747A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
| 01/07/1999 | CA2295326A1 Cardiotrophin-like cytokine |
| 01/07/1999 | CA2295325A1 Method of mapping restriction sites in polynucleotides |
| 01/07/1999 | CA2295319A1 New human cathepsin |
| 01/07/1999 | CA2295318A1 Human extracellular matrix proteins |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295305A1 Neuronal stem cell gene |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295301A1 Plant and viral promoters |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2294604A1 Transgenic animals expressing human fc receptors |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | CA2290718A1 Improved bacillus thuringiensis toxin |
| 01/06/1999 | CN1204370A A funguns wherein areA, pepC and/or pepE genes have been inactivated |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1204368A Cellulases, genes encoding them and uses thereof |
| 01/06/1999 | CN1204367A Antifungal proteins |
| 01/06/1999 | CN1204366A Antifungal protein |